EUVIMEDEUVIMED entdecken
Crossref

Toxicological and Liver Antioxidant Evaluation of Phillygenin Following Acute and Sub‐Chronic Oral Administration

Jiyu Qian iD, Kang Zhang, Guowei Xu, Bingbing Meng, Lei Wang, Jianxi Li iD, Xiaomeng Chai, Jingyan Zhang, Haipeng Feng iD

Journal of Applied Toxicology · 2026-12 · 46 (12) · 4683-4696

DOI: 10.1002/jat.70224 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Applied Toxicology, online erschienen am 06.05.2026. Verfasst von Jiyu Qian und 8 weiteren Autor:innen. Beteiligte Einrichtung: Lanzhou Institute of Husbandry and Pharmaceutical Sciences, Chinese Academy of Agricultural Sciences, Lanzhou, China. Hauptthemen laut MEDLINE: Antioxidants, Liver. Die Arbeit nennt 41 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Central Public-interest Scientific Institution Basal Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phillygenin (PHI), a bioactive ligand extracted from Forsythia suspensa , has garnered considerable attention due to its potent medicinal properties in antioxidant and antiviral. However, comprehensive toxicological data supporting its safe application remain scarce. In the present study, the oral safety profile of PHI was assessed following the Organization for Economic Cooperation and Development (OECD) guidelines 423 and 407. For acute toxicity assay, a single dose of 5000 mg/kg body weight (BW) of PHI was given orally to KM mice, with clinical observations maintained for 14 days. No treatment‐related mortality or toxic manifestations were observed, indicating an LD 50 exceeding 5000 mg/kg BW. In the 28‐day sub‐chronic toxicity assay, SD male/female mice received PHI at 5000, 15000, and 25,000 mg/kg BW. Across all dose groups, no adverse effects were observed in clinical signs, organ to weight ratio, body weight, food and water consumption, and biochemical parameters. Additionally, histopathological examination revealed normal organ status. To further explore hepatic functional response, antioxidant indices and key drug‐metabolizing enzymes were quantified in rat liver. PHI significantly enhanced hepatic antioxidant capacity, reflected by increased SOD and GSH levels and reduced MDA content. Moreover, PHI markedly suppressed the transcription level and protein expression of PXR and its downstream enzyme CYP3A1, suggesting a modulatory effect on xenobiotic metabolism. Collectively, these findings demonstrate that PHI exhibits a wide margin of oral safety and exerts beneficial regulatory effects on hepatic antioxidant function. This systematic evaluation provides essential evidence supporting the potential use of PHI as a safe antiviral and antioxidant agent in veterinary clinical application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntioxidantsLiverAnimalsMaleFemaleAdministration, OralToxicity Tests, AcuteMiceToxicity Tests, SubchronicRatsDose-Response Relationship, DrugLethal Dose 50Biphenyl CompoundsRats, Sprague-DawleyLignans

Stichwörter der Autor:innen

acute toxicityantioxidationphillygeninsafety evaluationsub‐chronic toxicity

Substanzen

AntioxidantsphillygeninBiphenyl CompoundsLignans

Autor:innen und Institutionen

  • Lanzhou Institute of Husbandry and Pharmaceutical Sciences, Chinese Academy of Agricultural Sciences, Lanzhou, China.
  • College of Veterinary Medicine, Gansu Agricultural University, Lanzhou, China.

ORCID-Profile: Jiyu Qian, Jianxi Li, Haipeng Feng

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Central Public-interest Scientific Institution Basal Research Fund
  • engineering project for scientific & technological Innovation of CAAS

Zitieren

APA

Qian, J., Zhang, K., Xu, G., Meng, B., Wang, L., Li, J., Chai, X., Zhang, J., & Feng, H. (2026). Toxicological and Liver Antioxidant Evaluation of Phillygenin Following Acute and Sub‐Chronic Oral Administration. Journal of Applied Toxicology, 46(12), 4683-4696. https://doi.org/10.1002/jat.70224

Vancouver

Qian J, Zhang K, Xu G, Meng B, Wang L, Li J, et al. Toxicological and Liver Antioxidant Evaluation of Phillygenin Following Acute and Sub‐Chronic Oral Administration. Journal of Applied Toxicology. 2026;46(12):4683-4696. doi:10.1002/jat.70224

BibTeX
@article{Qian2026,
  author = {Qian, Jiyu and Zhang, Kang and Xu, Guowei and Meng, Bingbing and Wang, Lei and Li, Jianxi and Chai, Xiaomeng and Zhang, Jingyan and Feng, Haipeng},
  title = {Toxicological and Liver Antioxidant Evaluation of Phillygenin Following Acute and Sub‐Chronic Oral Administration},
  journal = {Journal of Applied Toxicology},
  year = {2026},
  volume = {46},
  number = {12},
  pages = {4683--4696},
  doi = {10.1002/jat.70224}
}
Kostenlos starten →